1. Introduction {#sec1}
===============

14-3-3 refers to a family of homologous proteins that consist of seven genetic loci or isoforms (*β*, *γ*, *ε*, *η*, *σ*, *ζ*, and *τ*) in vertebrates. The name 14-3-3 was given based on the fraction number and migration position on DEAE-cellulose chromatography and subsequent starch-gel electrophoresis during its initial biochemical purification process \[[@B1]\]. 14-3-3 proteins exist as homo- or heterodimers, in which each 14-3-3 monomer shares a similar helical structure and forms a conserved concave amphipathic groove that binds to target proteins via specific phosphoserine/phosphothreonine-containing motifs \[[@B2]--[@B7]\]. Through protein-protein interactions, 14-3-3 functions by altering the conformation, stability, subcellular localization, or activity of its binding partners. To date, 14-3-3 proteins have been shown to interact with hundreds of proteins and are implicated in the regulation of a multitude of cellular processes \[[@B8], [@B9]\].

14-3-3 proteins are highly expressed in the brain, comprising \~1% of its total soluble proteins. Thus, it comes to no surprise that 14-3-3 proteins are involved in a variety of neuronal processes, such as neurite outgrowth, neural differentiation, migration and survival, ion channel regulation, receptor trafficking, and neurotransmitter release \[[@B10]--[@B12]\]. In addition, 14-3-3 proteins are genetically linked to several neurological disorders, including neurodegenerative diseases (e.g., Parkinson\'s, Alzheimer\'s, and Creutzfeldt-Jakob diseases), neurodevelopmental diseases (e.g., Lissencephaly), and neuropsychiatric disorders (e.g., schizophrenia and bipolar disorder) \[[@B13]--[@B15]\], thus making them a potential therapeutic target \[[@B16], [@B17]\]. In recent years, a number of small molecule 14-3-3 modulators have been discovered that could be used to either stabilize or inhibit 14-3-3 protein-protein interactions \[[@B18], [@B19]\]. However, as 14-3-3 proteins are involved in diverse cellular processes, it is highly desirable to further characterize and develop compounds that have enhanced isoform specificity as well as can selectively modulate the 14-3-3 interaction with a critical target in a particular pathway.

14-3-3 proteins are generally found in the cytoplasmic compartment of eukaryotic cells. In mature neurons, however, certain 14-3-3 isoforms are particularly enriched at synapses, suggesting their potential involvement in synaptic transmissions \[[@B20], [@B21]\]. Indeed, evidence accumulated in the last two decades reveals that 14-3-3 is an important modulator of synaptic neurotransmissions and plasticity. In this review, we will discuss the functional role of 14-3-3 proteins in the regulation of glutamatergic synapses.

2. Functions of 14-3-3 at the Presynaptic Site {#sec2}
==============================================

Early evidence that 14-3-3 might regulate synaptic transmission and plasticity came from genetic and functional studies of the fruit fly *Drosophila*. The gene *leonardo* encodes 14-3-3*ζ*, one of the two *Drosophila* 14-3-3 homologs that is abundantly and preferentially expressed in mushroom body neurons. Mutant *leo* alleles with reduced 14-3-3*ζ* proteins exhibit significant deficits in olfactory learning and memory, suggesting a functional role of 14-3-3 in these processes \[[@B22]\]. A subsequent study further determined that the 14-3-3*ζ* protein progressively accumulates to the synaptic boutons during maturation of the neuromuscular junction (NMJ), where it colocalizes with the synaptic vesicles containing the neurotransmitter glutamate \[[@B23]\]. Based on electrophysiological analyses, *Leonardo* mutants show impaired presynaptic functions at NMJ, including reduced endogenous excitatory junctional currents (EJCs), impaired transmission fidelity, and loss of long-term augmentation and posttetanic potentiation (PTP). The evoked transmission deficit in *leo* is more severe under lower external Ca^2+^ concentration, suggesting a possible defect in Ca^2+^-dependent presynaptic transmission in the absence of 14-3-3*ζ* proteins.

Following those studies in *Drosophila* NMJs, the involvement of 14-3-3 proteins in the presynaptic site of glutamatergic synapses was further investigated in the vertebrate nervous system. One potential mechanism is thought to be mediated by 14-3-3 binding to RIM1*α*, an active zone protein that is essential for presynaptic short- and long-term plasticity \[[@B24], [@B25]\]. Early biochemical studies have provided the first evidence that 14-3-3 binds to RIM1*α* through its N terminal domain, raising the possibility that 14-3-3 regulates neurotransmitter release and synaptic plasticity through the regulation of RIM1*α* \[[@B26]\]. A later study further confirmed this protein-protein interaction and identified that PKA phosphorylation of serine-413 at RIM1*α* (pSer413) is critical for 14-3-3 binding \[[@B27]\]. Moreover, electrophysiological assays in cultured cerebellar neurons suggested that recruitment of 14-3-3 to RIM1*α* at pSer413 is required for a presynaptic form of long-term potentiation (LTP) at granule cell and Purkinje cell synapses in the mouse cerebellum \[[@B27]--[@B29]\]. However, apparently contradictory evidence came from later efforts to examine the involvement of 14-3-3 and RIM1*α* interaction in presynaptic long-term plasticity using *in vivo* animal models. In one of these studies, a line of knock-in mice was generated to substitute RIM1*α* serine-413 with alanine (S413A), thereby abolishing RIM1*α* phosphorylation at S413 and 14-3-3 binding. Surprisingly, electrophysiological examination of the RIM1*α* S413A knock-in mice failed to detect a significant defect in presynaptic LTP, either at parallel fiber or mossy fiber synapses \[[@B30]\]. In agreement with this finding, an acute *in vivo* rescue experiment showed that deficits of mossy fiber LTP in RIM1*α*^−/−^ mice can be rescued by expression of the phosphorylation site-deficient mutant of RIM1*α* (S413A) \[[@B31]\]. Thus, it remains unclear whether 14-3-3 binding to S413 phosphorylated RIM1*α* plays a significant role in the regulation of presynaptic long-term plasticity.

A better-understood action of 14-3-3 at the presynaptic site is its role as the modulator of ion channels \[[@B32], [@B33]\], which include voltage-gated calcium (Ca^2+^) channels that play a central role in neurotransmitter release by mediating Ca^2+^ influx at nerve terminals \[[@B34]\]. In particular, Ca~V~2.2 channels undergo cumulative inactivation after a brief, repetitive depolarization, thus markedly impacting the fidelity of synaptic transmission and short-term synaptic plasticity \[[@B35], [@B36]\]. 14-3-3 modulates inactivation properties of Ca~V~2.2 channels through its direct binding to the channel pore-forming *α*~1B~ subunit. In cultured rat hippocampal neurons, inhibition of 14-3-3 proteins in presynaptic neurons augments short-term depression, likely through promoting the closed-state inactivation of Ca~V~2.2 channels ([Figure 1](#fig1){ref-type="fig"}) \[[@B37]\]. As 14-3-3 binding can be regulated by specific phosphorylation of the *α*~1B~ subunit, this regulatory protein complex may provide a potential mechanism for phosphorylation-dependent regulation of short-term synaptic plasticity.

3. Functions of 14-3-3 at the Postsynaptic Site {#sec3}
===============================================

The role of 14-3-3 at the postsynaptic site emerged more recently from the studies of various 14-3-3 mouse models. One of them, the 14-3-3 functional knockout (FKO) mice, was generated by transgenic expression of difopein (dimeric fourteen-three-three peptide inhibitor) that antagonizes the binding of 14-3-3 proteins to their endogenous partners in an isoform-independent manner, thereby disrupting 14-3-3 functions \[[@B38]--[@B41]\]. Transgene expression is driven by the neuronal-specific Thy-1 promoter which produces variable expression patterns in the brains of different founder lines, making it possible to assess the behavioral and synaptic alterations associated with expression of the 14-3-3 inhibitor in certain brain regions \[[@B42], [@B43]\]. Inhibition of 14-3-3 proteins in the hippocampus impairs associative learning and memory behaviors and suppresses long-term potentiation (LTP) at hippocampal CA3-CA1 synapses of the 14-3-3 FKO mice \[[@B41]\]. Through comparative analyses of two different founder lines with distinct transgene expression patterns in the subregions of the hippocampus, it was further determined that postsynaptic inhibition of 14-3-3 proteins may contribute to the impairments in LTP and cognitive behaviors. These observations thus revealed a postsynaptic function for 14-3-3 proteins in regulating long-term synaptic plasticity in mouse hippocampus.

What might be the molecular targets of 14-3-3 proteins at the postsynaptic site of hippocampal synapses? In the 14-3-3 FKO mice, there is a significant reduction of the NMDA receptor-mediated synaptic currents in CA1 pyramidal neurons which express the 14-3-3 inhibitor. Consistently, the level of NMDA receptors (NMDARs), particularly GluN1 and GluN2A subunits, is selectively reduced in the postsynaptic density (PSD) fraction of 14-3-3 FKO mice that exhibit deficits in cognitive behaviors and hippocampal LTP \[[@B41]\]. Considering the critical role that NMDARs play in mediating LTP at hippocampal CA3-CA1 synapses \[[@B44]\], 14-3-3 proteins likely exert their effects on postsynaptic sites through the regulation of NMDA receptors, either directly or indirectly ([Figure 2](#fig2){ref-type="fig"}).

NMDARs are heterotetramers composed of two obligatory GluN1 subunits and two regulatory subunits derived from GluN (GluN2A-2D) and GluN3 subunits \[[@B45], [@B46]\]. 14-3-3 is known to promote surface expression of NMDA receptors in cerebellar neurons through its interaction with PKB-phosphorylated GluN2C subunits \[[@B47]\]. A more recent study also showed that inhibiting endogenous 14-3-3 proteins using difopein greatly attenuate GluN2C surface expression in cultured hippocampal neurons \[[@B48]\]. However, it remains to be determined whether 14-3-3 proteins directly interact with other subunits of NMDAR and have similar effects on their surface expression. Alternatively, 14-3-3 might indirectly regulate the PSD level of NMDARs by modulating other critical steps of NMDAR synaptic trafficking, such as dendritic transport and synaptic localization \[[@B45], [@B49]\]. Therefore, further studies are needed to better understand the exact mechanism underlying 14-3-3 proteins\' regulation of NMDA receptors. Interestingly, the synaptic level of certain 14-3-3 isoforms is reduced in GluN1 knockdown mice, but not by subchronic administration of an NMDAR antagonist in wild-type mice \[[@B50]\]. It raises a possibility that a reciprocal regulation between 14-3-3 and NMDARs may take place at the postsynaptic site.

14-3-3 proteins also modulate other glutamate receptors at the postsynaptic membrane. For example, 14-3-3 interacts with GluK2a, a subunit of the kainate receptor (KAR) that mediates postsynaptic transmission, synaptic plasticity, and neuronal excitability \[[@B51]\]. 14-3-3 binding slows desensitization kinetics of GluK2a-containing KARs. In 14-3-3 FKO mice, expression of the 14-3-3 inhibitor in CA3 neurons leads to a faster decay of KAR-EPSCs at hippocampal mossy fiber-CA3 synapses \[[@B52]\]. This study provides another potential mechanism by which 14-3-3 proteins regulate synaptic functions at the postsynaptic site.

In addition to modulating the level and biophysical properties of postsynaptic glutamate receptors, 14-3-3 functions by regulating synaptogenesis. In the 14-3-3 FKO mice, there is a reduction of both dendritic complexity and spine density in the cortical and hippocampal neurons where the 14-3-3 inhibitor is extensively expressed \[[@B53]\]. A similar reduction in dendritic spine density was observed in 14-3-3*ζ*-deficient mice in BALB/c background \[[@B54], [@B55]\]. On the contrary, overexpressing 14-3-3*ζ* in rat hippocampal neurons significantly increases spine density \[[@B56]\]. Collectively, studies on these animal models provide *in vivo* evidence for a significant role of 14-3-3 proteins in promoting the formation and maturation of dendritic spines.

While the molecular mechanism for 14-3-3 dependent regulation of synaptogenesis remains elusive, several *in vitro* studies have proposed 14-3-3 proteins as important regulators of cytoskeleton and actin dynamics, which are critical for controlling the shape, organization, and maintenance of dendritic spines in postsynaptic neurons \[[@B57], [@B58]\]. Earlier studies showed that 14-3-3*ζ* regulates actin dynamics through its direct interaction with phosphorylated cofilin (p-cofilin) \[[@B57]\]. Cofilin is a major actin depolymerizing factor. Reduction of p-cofilin enhances the activity of cofilin, promotes the turnover of actin filaments, and consequently destabilizes dendritic spines \[[@B55], [@B56]\]. Moreover, a different group identified cofilin and its regulatory kinase LIM-kinase 1 (LIMK1) as binding partners of 14-3-3*ζ* and suggested that interactions with the C-terminal region of 14-3-3*ζ* inhibit the binding of cofilin to F-actin \[[@B59]\]. However, a direct interaction between 14-3-3 and cofilin/p-cofilin was challenged by a later study, in which Sudnitsyna et al. demonstrated that 14-3-3 only weakly interacts with cofilin, and they suggested that 14-3-3 proteins most likely regulate actin dynamics through other regulatory kinases such as LIMK1 or slingshot 1 L phosphatase (SSH) \[[@B60]\]. In fact, 14-3-3*ζ* has been shown to directly bind with phosphorylated SSH and lower its ability to bind F-actin \[[@B58]\].

More recently, Toyo-oka et al. showed that 14-3-3*ε* and 14-3-3*ζ* bind to *δ*-catenin and potentially regulate actin dynamics through *δ*-catenin \[[@B11], [@B61]\]. Catenin activates the Rho family of GTPase that results in the phosphorylation and activation of LIMK1. Loss of 14-3-3 proteins results in stabilization of *δ*-catenin through the ubiquitin-proteasome system, thereby decreasing LIMK1 activity and reducing p-cofilin level. Therefore, it is possible that 14-3-3 proteins may promote F-actin formation and spinogenesis by interacting with multiple elements in the regulatory pathways of the actin polymerization/depolymerization cycles ([Figure 2](#fig2){ref-type="fig"}).

4. Conclusion {#sec4}
=============

The glutamatergic synapses mediate the majority of excitatory neurotransmission in the mammalian brain. Regulation of the property and connectivity of glutamatergic synapses represents a major mechanism for activity-dependent modification of synaptic strength and is critical for higher brain functions. 14-3-3 proteins have emerged as one of the important modulators at these synapses. It is particularly interesting that 14-3-3 binding and function are generally regulated by phosphorylation, which is a well-established molecular process underlying synaptic plasticity. Thus, 14-3-3 can potentially integrate multiple signaling pathways and plays a significant role in dynamic modification of glutamatergic synapses. As demonstrated by recent animal models, 14-3-3 deficiencies in rodent brain often result in the onset of abnormal behaviors, which might correspond to symptoms of neurological disorders.
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![14-3-3 regulates presynaptic short-term plasticity by modulating Ca~V~2.2 channel properties. 14-3-3 binding reduces cumulative inactivation of Ca~V~2.2 channels and sustains Ca^2+^ influx and neurotransmitter release (a). Inhibition of 14-3-3 accelerates Ca~V~2.2 channel inactivation and enhances short-term synaptic depression (b).](NP2018-8407609.001){#fig1}

![14-3-3 regulates NMDA receptors and actin dynamics at postsynaptic sites. (1) 14-3-3 proteins facilitate targeting of NMDARs to the postsynaptic density, thereby regulating long-term potentiation; (2) 14-3-3 proteins might promote spinogenesis by facilitating F-actin formation.](NP2018-8407609.002){#fig2}
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